GlassScriptPhysician profile
Howard Gale
NPI 1881600591
$3,409.08
in general payments reported to CMS, 2019-2025
29 companies · $706 in 2025
The $706 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $141 · 2020: $64.70 · 2021: $233 · 2022: $556 · 2023: $1,034 · 2024: $674 · 2025: $706.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,649 · Travel and Lodging: $765.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,649.22 |
| Travel and Lodging | $764.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $623.75 | 2019-2025 | Grafix Pl, Stravix Pl, Collagenase Santyl |
| Arthrex, INC. | $468.48 | 2023 | |
| Treace Medical Concepts, INC. | $417.60 | 2022-2024 | |
| Vilex LLC | $210.51 | 2025 | Dynex |
| Abbvie INC. | $204.18 | 2022-2025 | |
| Triad Life Sciences INC. | $201.22 | 2022 | |
| Organogenesis INC. | $184.67 | 2019-2023 | Puraply |
| Paragon 28, INC. | $94.21 | 2021 | |
| Depuy Synthes Sales INC. | $91.48 | 2023-2025 | Motoband, Gii, Healix Knotless Peek |
| Paratek Pharmaceuticals, INC. | $87.06 | 2024 | Nuzyra |
| Globus Medical, INC. | $81.20 | 2025 | Senza |
| Horizon Therapeutics Plc | $80.70 | 2019-2023 | Krystexxa |
| Nevro Corp. | $66.43 | 2022-2023 | Senza |
| Solventum Corporation | $63.97 | 2025 | V.A.C.Ulta, Prevena, V.A.C. Dermatac |
| Trice Medical, INC. | $63.59 | 2023 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $62.62 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $57.60 | 2022-2023 | Seglentis |
| Convatec INC. | $53.73 | 2024-2025 | |
| Averitas Pharma INC. | $52.65 | 2023-2025 | Qutenza |
| Amgen INC. | $42.47 | 2024-2025 | Krystexxa |
| Acera Surgical, INC. | $37.13 | 2021-2023 | Restrata Wound Matrix |
| Medtronic, INC. | $31.87 | 2023 | Intellis Adaptivestim |
| Next Science LLC | $25.21 | 2023 | Surgx, Blastx, Xperience |
| Abbott Laboratories | $24.15 | 2021 | |
| Biocomposites INC | $20.99 | 2025 | Stimulan |
| Ibsa Pharma INC. | $19.56 | 2024 | Licart, Tirosint |
| Melinta Therapeutics, LLC | $15.84 | 2019 | |
| Kci USA, INC. | $13.59 | 2020 | |
| Allergan, INC. | $12.62 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Gale listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.